CJEU clarifies “First” Marketing Authorization in SPC Applications
A Supplementary Protection Certificate (SPC) is an intellectual property right that serves as an extension to a patent right. It extends patent protection for medicinal products which must undergo testing and clinical trials before being authorised to be placed on the EU market. SPCs can last for up to five years, depending on the time […]
